1. Home
  2. HTBI vs PCRX Comparison

HTBI vs PCRX Comparison

Compare HTBI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBI
  • PCRX
  • Stock Information
  • Founded
  • HTBI 1926
  • PCRX 2006
  • Country
  • HTBI United States
  • PCRX United States
  • Employees
  • HTBI N/A
  • PCRX N/A
  • Industry
  • HTBI Savings Institutions
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBI Finance
  • PCRX Health Care
  • Exchange
  • HTBI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • HTBI 641.9M
  • PCRX 1.2B
  • IPO Year
  • HTBI 2012
  • PCRX 2011
  • Fundamental
  • Price
  • HTBI $36.94
  • PCRX $26.88
  • Analyst Decision
  • HTBI Buy
  • PCRX Buy
  • Analyst Count
  • HTBI 4
  • PCRX 10
  • Target Price
  • HTBI $39.00
  • PCRX $29.30
  • AVG Volume (30 Days)
  • HTBI 42.1K
  • PCRX 892.8K
  • Earning Date
  • HTBI 01-23-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • HTBI 1.30%
  • PCRX N/A
  • EPS Growth
  • HTBI N/A
  • PCRX N/A
  • EPS
  • HTBI 3.20
  • PCRX N/A
  • Revenue
  • HTBI $193,436,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • HTBI N/A
  • PCRX $5.14
  • Revenue Next Year
  • HTBI $3.67
  • PCRX $2.44
  • P/E Ratio
  • HTBI $11.33
  • PCRX N/A
  • Revenue Growth
  • HTBI 4.69
  • PCRX 4.40
  • 52 Week Low
  • HTBI $23.55
  • PCRX $11.16
  • 52 Week High
  • HTBI $38.99
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • HTBI 61.69
  • PCRX 77.75
  • Support Level
  • HTBI $35.68
  • PCRX $25.06
  • Resistance Level
  • HTBI $38.22
  • PCRX $27.10
  • Average True Range (ATR)
  • HTBI 1.07
  • PCRX 1.45
  • MACD
  • HTBI 0.30
  • PCRX 0.28
  • Stochastic Oscillator
  • HTBI 81.24
  • PCRX 86.23

About HTBI HomeTrust Bancshares Inc.

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: